1) antiangiogenic agent
血管抑制剂
1.
Altering the balance between proangiogenic and antiangiogenic factors by some antiangiogenic agents may effectively inhibit the growth,expansion and recurrence of the tumor,which has lately become the hot topic in the tumor research.
肿瘤生长和转移具有血管依赖性,应用肿瘤血管抑制剂改变肿瘤血管生长促进因子和抑制因子的平衡可有效地抑制肿瘤生长、转移和复发,是近年来肿瘤研究的新热点之一,也是肿瘤防治的又一条新途径。
2) Chinese traditional medicine vas inhibitor
中药血管抑制剂
1.
Objective:To investigate the clinical benefit of Chinese traditional medicine vas inhibitor Ginsenoside(Rg3) combined with Paclitaxel chemotherapy on the patients with gastric carcinoma after surgery and liver metastasis.
目的:探讨中药血管抑制剂人参皂苷Rg3联合紫杉醇治疗胃癌术后肝转移的临床疗效。
3) angiogenesis inhibitors
血管生成抑制剂
1.
Advances in research on screening models of tumor angiogenesis inhibitors;
肿瘤血管生成抑制剂筛选模型的研究进展
2.
New agents of traditional cytotoxity, targeted agents such as protein tyrosine kinase inhibitors, tumor angiogenesis inhibitors and gene therapy are focused in this paper.
文章综述近几年来抗肿瘤药物新进展,包括新的细胞毒性抗肿瘤药,针对关键靶点的新型抗肿瘤药如酪氨酸激酶抑制剂、血管生成抑制剂以及基因疗法等。
3.
Feasibility for inhibiting tumor metastasis with Chinese herbal medicines as angiogenesis inhibitors;
抑制肿瘤血管生成是控制肿瘤生长和转移的重要途径之一,以肿瘤血管形成为靶点的血管生成抑制剂研究已成为当前肿瘤基础理论和临床研究的热点。
4) angiogenesis inhibitor
血管生成抑制剂
1.
Study of angiogenesis inhibitor NM-3 on the growth of human gastric cancer;
血管生成抑制剂NM-3抑制胃癌生长机制研究
2.
Objective To study the effect of angiogenesis inhibitor and its combine with chemical drug in suppressing the growth of adenoid cystic carcinoma (ACC).
目的 探讨单独使用血管生成抑制剂及其与化疗药联合对腺样囊性癌裸鼠移植瘤生长的影响。
3.
Objective:To investigate the effects of tumor angiogenesis inhibitor endostatin on healing of gastrointestinal anastomoses in the dog.
目的 :研究肿瘤血管生成抑制剂内皮抑素 (endostatin)对胃癌术后胃肠吻合口愈合的影响。
6) angiogenesis inhibitor
血管形成抑制剂
1.
Experimental study of angiogenesis inhibitor TNP-470 on suppression of tumour growth and microvascular angiogenesis;
血管形成抑制剂TNP-470抑制肿瘤生长和微血管形成的实验研究
2.
RESULTS Treated with angiogenesis inhibitor thalidomide, the basement membrane of capillary became unintegrated, the endothelial cells degenerated, and the procedure of angio genesis was damaged.
目的 为探讨血管形成抑制剂反应停对增生性瘢痕的治疗机制提供形态学依据 。
补充资料：血管紧张素转换酶抑制剂
血管紧张素转换酶抑制剂
converting enzyme inhibitor of angiotensin
能够抑制血管紧张素转换酶的活性、使血管紧张素Ⅰ不能转换成血管紧张素Ⅱ的物质，如替普罗肽(又称SQ20881）及卡托普利(又称SQ14225）。用于肾血管性高血压及高血压危象。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条